Palek Lukás, Dvorák Jaroslav, Svobodová Michaela, Buchta Vladimír, Jampílek Josef, Dolezal Martin
Department of Medicinal Chemistry and Drug Control, Charles University Prague, Faculty of Pharmacy in Hradec Králové, Hradec Králové, Czech Republic.
Arch Pharm (Weinheim). 2008 Jan;341(1):61-5. doi: 10.1002/ardp.200700119.
This paper describes preparation and biological evaluation of pyrazinamide analogues. Pyrazinamide with its simple structure gives a good opportunity for further modification regarding an increase of its antimycobacterial activity. We prepared a series of compounds derived from pyrazine-2,5-dicarbonitrile with arylamino substitution in position 3. All compounds were assayed in vitro against major Mycobacterium and various Fungi species. The best activity was found in 3-{[3-(trifluoromethyl)phenyl]amino}pyrazine-2,5-dicarbonitrile 11 with the value of 6.25 micromol(-1) against M. tuberculosis H(37)Rv and moderate activity against minor Mycobacterium pathogens.
本文描述了吡嗪酰胺类似物的制备及生物学评价。吡嗪酰胺结构简单,为进一步修饰以提高其抗分枝杆菌活性提供了良好契机。我们制备了一系列由3-芳基氨基取代的2,5-二氰基吡嗪衍生而来的化合物。所有化合物均针对主要分枝杆菌和各种真菌进行了体外测定。发现3-{[3-(三氟甲基)苯基]氨基}吡嗪-2,5-二腈11的活性最佳,对结核分枝杆菌H(37)Rv的值为6.25微摩尔(-1),对次要分枝杆菌病原体具有中等活性。